Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms × Omeprazole × Clear all

Phase

Phase 1 3 Phase 2 2 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Precancerous Gastric Lesions 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Barrett Esophagus 1 Atrophy 1

Interventions

Cyclophosphamide 131 Docetaxel 125 Paclitaxel 111 Trastuzumab 105 Tamoxifen 97 Capecitabine 93 Letrozole 82 Epirubicin 65 Doxorubicin 62 exemestane 57 Fulvestrant 56 Anastrozole 55 Radiotherapy 53 Fluorouracil 53 pertuzumab 34 Gemcitabine 32 Vinorelbine 31 Goserelin 30 Carboplatin 30 Methotrexate 26 Chemotherapy, Adjuvant 26 eribulin 24 Zoledronic Acid 24 Bevacizumab 24 Lapatinib 23 ribociclib 21 palbociclib 20 pegfilgrastim 18 abemaciclib 17 Drug Therapy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05646862 2026-02-05

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡